|52 Week Results||Augment Injectable||Autograft||Non-Inferiority|
|Mean± sd||Mean± sd||p-value|
|Foot Function Index||15.0 ± 17.5||17.4 ± 20.4||< 0.001|
|AOFAS Ankle-Hindfoot Scale||80.0 ± 13.9||78.5 ± 17.0||< 0.001|
|Fusion Site Pain||12.2 ± 19.4||13.0 ± 23.5||< 0.001|
|Weight Bearing Pain||13.0 ± 20.0||15.6 ± 25.4||< 0.001|
|Graft Site Pain||0||6.2 ± 16.6||< 0.001|
|SF-12 (PCS)||44.6 ± 8.5||45.0 ± 9.7||< 0.001|
|*Lower FFI and pain scores indicate better outcome. Higher AOFAS and SF-12 scores indicate better outcome.|
Timothy Daniels, MD Presents Results From Augment™ Injectable Bone Graft Clinical Trial
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.